http://www.smh.com.au/business/marke...424-376kl.html
Excerpt : "The company was rocked yesterday (Wednesday) after it failed to win regulatory approval for the release of its painkiller drug, Moxduo, in the US. The stock dropped from 70 cents to 14 cents on the news."
Biotech is not for the fainthearted or those who want short term immediate gratification, month by month or as some on this thread seem to expect. week by week. It has taken PEB a long long while to get to where they are and some of the shareholders with PEB have been there for over 5 years or more. And the gains they are sitting on are still in excess of 400%.
At this rate, one suspects some of the traders here are going to have heart attacks!